Dextromethorphan Market Size

Dextromethorphan Market size was over USD 396.34 Million in 2023 and is expected to exceed USD 685.12 Million by the end of 2036, witnessing over 4.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of dextromethorphan is evaluated at USD 413.38 Million.. The major factor attributed to market growth is the rising cases of severe cough, and other respiratory problems owing to allergies, pollution, and several other factors. A recently published report of 2022, stated that cough was among the most common medical complaints that were registered across the globe and accounted for almost 30 million clinical visits per year.

In addition to the aforementioned factors, the rising demand for effective antibiotics to treat upper respiratory tract infection (UTRI) is expected to increase the production rate of dextromethorphan during the analysis period. Moreover, the escalation in other conditions such as asthma and lung diseases is also projected to rise in the utilization of dextromethorphan. Also, other factors that are projected to propel the global population to adopt dextromethorphan is the high prevalence of contagious diseases such as COVID-19, influenza, diphtheria, and others coupled with other respiratory problems in the world. Furthermore, the increased research and development activities along with the increased focus on the development of novel drugs for treating cough problems, and high healthcare expenditure are also expected to create a positive outlook for the expansion of market size in the next few years. The burgeoning geriatric population and people with low immune systems owing to unhealthy lifestyles are also forecasted to bring in lucrative growth opportunities for market growth during the assessment period.